TGHI yields 2000000.00% · PFE yields 6.13%● Live data
📍 TGHI pulled ahead of the other in Year 1
Combined, TGHI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TGHI + PFE for your $10,000?
Touchpoint Group Holdings, Inc., through its subsidiaries, operates as a software development company in the United States, Hong Kong, China, and the United Kingdom. The company engages in the software development, design, integration, support, and maintenance services of a robust fan engagement platform that enhances fan experience and drives commercial aspects of the sport and entertainment business. Its fan engagement platform also brings users closer to the action by enabling them to engage with clubs, favorite players, peers, and relevant brands through various features, including live streaming, access to limited edition merchandise, gamification, user rewards, third party branded offers, credit cards, and related benefits. The company was formerly known as One Horizon Group, Inc. and changed its name to Touchpoint Group Holdings, Inc. in September 2019. Touchpoint Group Holdings, Inc. was incorporated in 1972 and is based in Miami, Florida.
Full TGHI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.